Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cord Blood Stem Cells

Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia

Abstract

In unrelated cord blood (UCB) transplantation, survival has been shown to correlate with the degree of HLA matching. Thus, to extend transplant access to different ethnic backgrounds, many western UCB transplantation banks now encourage donation from non-Caucasians. Until recently, Saudi Arabia did not have a national UCB bank. In this study we report our experience in UCB transplantation in children using units procured from western cord blood banks. A total of 97 children underwent unrelated UCB transplantation at King Faisal Specialist Hospital and Research Center (KFSHRC), of which 95 were of Arab ethnicity. A total of 30 patients had malignant disorders, 25 patients had non-malignant hematological disorders and 42 patients had inborn errors. Conditioning was according to disease, with six patients receiving reduced-intensity regimens. In all, 46 patients received one-Ag-mismatched units and 51 received two-Ag-mismatched units. Engraftment occurred in 93% of patients, the 100-TRM was 15%, acute GVHD developed in 20% of patients and chronic GVHD occurred in 9% of patients. The 5-year OS and EFS estimates were 52 and 43%, respectively. The search for UCB transplantation units for Saudi patients in western banks yielded reasonably compatible units for our patients; the results are consistent with published data. Our data are encouraging for UCB transplant programs in countries in which there are no national UCB transplantation banks.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14: 1057–1063.

    Article  CAS  PubMed  Google Scholar 

  2. Pinto FO, Roberts I . Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol 2008; 141: 309–324.

    CAS  PubMed  Google Scholar 

  3. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris R, Wagner J et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073–1082.

    Article  PubMed  Google Scholar 

  4. Díaz de Heredia C, Ortega JJ, Díaz MA, Olivé T, Badell I, González-Vicent M et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant 2008; 41: 627–633.

    Article  PubMed  Google Scholar 

  5. Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006; 37: 469–477.

    Article  CAS  PubMed  Google Scholar 

  6. Sawczyn KK, Quinones R, Malcolm J, Foreman N, Garrington T, Gore L et al. Cord blood transplant in childhood ALL. Pediatr Blood Cancer 2005; 45: 964–670.

    Article  PubMed  Google Scholar 

  7. Isoyama K, Oda M, Kato K, Nagamura-Inoue T, Kai S, Kigasawa H et al. Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan. Bone Marrow Transplant 2009; (e-pub ahead of print).

  8. Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA et al. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant 2005; 11: 637–646.

    Article  CAS  PubMed  Google Scholar 

  9. Barker JN, Rocha V, Scaradavou A . Optimizing unrelated donor cord blood transplantation. Biol Blood Marrow Transplant 2008; 15: 154–161.

    Article  Google Scholar 

  10. Wall DA, Chan KW . Selection of cord blood unit(s) for transplantation. Bone Marrow Transplant 2008; 42: 1–7.

    Article  CAS  PubMed  Google Scholar 

  11. Novelo-Garza B, Limon-Flores A, Guerra-Marquez A, Luna-Bautista F, Juan-Shum L, Montero I et al. Establishing a cord blood banking and transplantation program in Mexico: a single institution experience. Transfusion 2008; 48: 228–236.

    PubMed  Google Scholar 

  12. Wu JY, Liao C, Xu ZP, Chen JS, Gu SL, Huang YN et al. Banking and transplantation of umbilical cord blood in Guangzhou, China. Cytotherapy 2006; 8: 488–497.

    Article  CAS  PubMed  Google Scholar 

  13. Mugishima H, Takahashi T, Nagamura T, Asano S, Saito H . Umbilical cord blood for unrelated bone marrow replacement; Asia bank and Japan cord blood bank network update. Int J Hematol 2002; 76 (Suppl 2): 284–286.

    Article  PubMed  Google Scholar 

  14. Meyer-Monard S, Passweg J, Troeger C, Eberhard H-P, Roosnek E, Nicoloso de Faveri G et al. Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells. Bone Marrow Transplant 2009; 43: 771–778.

    Article  CAS  PubMed  Google Scholar 

  15. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2967.

    Article  CAS  PubMed  Google Scholar 

  16. Long GD, Laughlin M, Madan B, Kurtzberg J, Gasparetto C, Morris A et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 9: 772–780.

    Article  PubMed  Google Scholar 

  17. Knutsen AP, Wall DA . Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000; 20: 466–476.

    Article  CAS  PubMed  Google Scholar 

  18. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008; 14: 282–289.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bradley MB, Satwani P, Baldinger L, Morris E, van de Ven C, Del Toro G et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant 2007; 40: 621–631.

    Article  CAS  PubMed  Google Scholar 

  20. Rocha V, Mohty M, Gluckman E, Rio B . Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol 2009; 21 (Suppl 1): S31–S34.

    Article  PubMed  Google Scholar 

  21. Awaya T, Kato T, Niwa A, Hiramatsu H, Umeda K, Watanabe KI et al. Successful cord blood transplantation using a reduced-intensity conditioning regimen for advanced childhood-onset cerebral adrenoleukodystrophy. Pediatr Transplant 2009; (e-pub ahead of print).

  22. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410–2415.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 14; 344: 1815–1822.

    Article  Google Scholar 

  24. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  25. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    Article  CAS  PubMed  Google Scholar 

  26. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373–381.

    Article  CAS  PubMed  Google Scholar 

  27. Shimada K, Narimatsu H, Morishita Y, Kohno A, Saito S, Kato Y . Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient. Bone Marrow Transplant 2006; 37: 787–788.

    Article  CAS  PubMed  Google Scholar 

  28. Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T . Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. Bone Marrow Transplant 2007; 40: 85–87.

    Article  CAS  PubMed  Google Scholar 

  29. Isoyama K, Ohnuma K, Ikuta K, Toyoda Y, Nakajima F, Yamada K et al. Unrelated cord blood transplantation for second hemopoietic stem cell transplantation. Pediatr Int 2003; 45: 268–274.

    Article  PubMed  Google Scholar 

  30. Ohwada C, Nakaseko C, Ozawa S, Takeuchi M, Shono K, Koizumi M et al. Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML. Bone Marrow Transplant 2004; 34: 999–1000.

    Article  CAS  PubMed  Google Scholar 

  31. Ayas M, Al-Jefri A, Al-Seraihi A, Al-Mahr M, Al-Ahmari A, El-Solh H . Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning. Biol Blood Marrow Transplant 2008; 14: 445–448.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Ayas.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayas, M., Al-Seraihi, A., Al-Jefri, A. et al. Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia. Bone Marrow Transplant 45, 1281–1286 (2010). https://doi.org/10.1038/bmt.2009.350

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.350

Keywords

This article is cited by

Search

Quick links